252 related articles for article (PubMed ID: 8196623)
1. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.
Drummond IA; Rupprecht HD; Rohwer-Nutter P; Lopez-Guisa JM; Madden SL; Rauscher FJ; Sukhatme VP
Mol Cell Biol; 1994 Jun; 14(6):3800-9. PubMed ID: 8196623
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes.
Laity JH; Chung J; Dyson HJ; Wright PE
Biochemistry; 2000 May; 39(18):5341-8. PubMed ID: 10820004
[TBL] [Abstract][Full Text] [Related]
3. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
[TBL] [Abstract][Full Text] [Related]
4. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
Hamilton TB; Barilla KC; Romaniuk PJ
Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
[TBL] [Abstract][Full Text] [Related]
5. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
[TBL] [Abstract][Full Text] [Related]
7. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
[TBL] [Abstract][Full Text] [Related]
8. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
[TBL] [Abstract][Full Text] [Related]
9. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
[TBL] [Abstract][Full Text] [Related]
10. RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.
Nishikawa T; Wojciak JM; Dyson HJ; Wright PE
Biochemistry; 2020 Oct; 59(40):3889-3901. PubMed ID: 32955251
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.
Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D
J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666
[TBL] [Abstract][Full Text] [Related]
12. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B
Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein.
Laity JH; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11932-5. PubMed ID: 11050227
[TBL] [Abstract][Full Text] [Related]
14. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene.
Anant S; Axenovich SA; Madden SL; Rauscher FJ; Subramanian KN
Oncogene; 1994 Nov; 9(11):3113-26. PubMed ID: 7936634
[TBL] [Abstract][Full Text] [Related]
15. RNA binding by the Wilms tumor suppressor zinc finger proteins.
Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
[TBL] [Abstract][Full Text] [Related]
16. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1.
Zhai G; Iskandar M; Barilla K; Romaniuk PJ
Biochemistry; 2001 Feb; 40(7):2032-40. PubMed ID: 11329270
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
[TBL] [Abstract][Full Text] [Related]
18. Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.
Wang D; Horton JR; Zheng Y; Blumenthal RM; Zhang X; Cheng X
Nucleic Acids Res; 2018 May; 46(8):3864-3877. PubMed ID: 29294058
[TBL] [Abstract][Full Text] [Related]
19. The Wilms' tumor suppressor gene WT1 is negatively autoregulated.
Rupprecht HD; Drummond IA; Madden SL; Rauscher FJ; Sukhatme VP
J Biol Chem; 1994 Feb; 269(8):6198-206. PubMed ID: 8119964
[TBL] [Abstract][Full Text] [Related]
20. Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.
Englert C; Vidal M; Maheswaran S; Ge Y; Ezzell RM; Isselbacher KJ; Haber DA
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11960-4. PubMed ID: 8618823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]